Article

PCSK9 Eligibility Concerns Highlight AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
5 experts in this video
5 experts in this video
1 expert is featured in this series.
1 expert is featured in this video series.
Related Content
3D visualization of red blood cells | Image Credit: © Thipphaphone - stock.adobe.com
May 20th 2025

Ruxolitinib Plus Siremadlin Yielded Superior Spleen Volume Reduction in Patients With Myelofibrosis

Alexandra Gerlach, Associate Editor
Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
May 20th 2025

Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Glofit-GemOx in R/R DLBCL: FDA Advisory Committee Reviews STARGLO Phase 3 Results for Transplant-Ineligible Patients
Published: May 20th 2025 | Updated: May 20th 2025

Glofit-GemOx in R/R DLBCL: FDA Advisory Committee Reviews STARGLO Phase 3 Results for Transplant-Ineligible Patients

Alana Hippensteele, Lead Editor
pharmacy focus oncology podcast
May 19th 2025

Insights from a Pharmacy Times Peer Exchange: Real-World Outcomes and Supportive Care

Alexandra Gerlach, Associate Editor
The doctor provides a detailed explanation of the human respiratory system using a model of lung concept
May 20th 2025

Declines in Pediatric Pneumococcal Complicated Pneumonia Evident Following Introduction of Higher Valent Vaccines

Luke Halpern, Assistant Editor
A Pharmacist’s Guide to Diabetic Ketoacidosis
May 20th 2025

A Pharmacist’s Guide to Diabetic Ketoacidosis

Ladona Mansour, PharmD Candidate Saro Arakelians, PharmD